Boehringer Ingelheim has announced that Vetmedin Chewable Tablets have been licensed for treating pre-clinical dilated cardiomyopathy (DCM) in Doberman Pinschers¹. 

Boehringer says DCM is the most common form of cardiomyopathy in dogs and the second most…

Boehringer Ingelheim has announced that Vetmedin has been granted a new licensed indication: for the treatment of asymptomatic mitral valve disease (MVD), and cardiomegaly.

The research on which the new indication is based is described by Boehringer…

Boehringer Ingelheim has launched Vetmedin (pimobendan) 1.5 mg/ml oral solution for dogs in Great Britain, offering a new treatment option for smaller cardiac patients and ones that don't take tablets easily.

The company says the two main benefits of…